gene

ABCG2

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about ABCG2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

230Connections
0Hypotheses
0Analyses
50Outgoing
50Incoming

Summary

ABCG2 is a gene implicated in neurodegeneration research. Key relationships include: associated with, activates, therapeutic target. Associated with Als, Alzheimer, Anxiety. Connected to 152 entities in the SciDEX knowledge graph.

View on Wiki →

🧬 Gene Info
Gene SymbolABCG2
Full NameATP Binding Cassette Subfamily G Member 2
Chromosome4q22.1
Protein TypeTransporter
Functionencodes a 72 kDa half-transporter that functions as a homodimer at the blood-brain barrier.
Molecular Weight72 kDa
Exons16
PathwaysAkt, Apoptosis, Autophagy, Blood-Brain Barrier, Cell Cycle
Ensembl IDENSG00000118777
GeneCardsABCG2
Human Protein AtlasABCG2
Homodimeric architectureTwo ABCG2 monomers assemble via extensive TMD interactions to form a functional transporter with a central drug-binding cavity
Substrate specificityPreferentially transports sulfated and glucuronidated conjugates, porphyrins, dietary flavonoids, urate, and various chemotherapeutic agents
Cooperative transportSome substrates show positive cooperativity, with binding at one site enhancing transport at the other
Associated DiseasesAlzheimer, Alzheimer'S Disease, Anxiety, Dementia, Depression
InteractionsZBP1, MFN2, GSDMD, RIPK1, RAB7A, CAT
KG Connections230 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

ABCG2 (BCRP) - ATP Binding Cassette Subfamily G Member 2

gene · 1180 words

blood-brain-barrier

general · 4426 words

bbb-transport-mechanisms

mechanism · 3506 words

Blood-Brain Barrier Breakdown in Neurodegeneration

mechanism · 3474 words

blood-brain-barrier-endothelial-cells

cell_type · 3383 words

Riluzole ALS Trials

clinical · 3263 words

Pathway Diagram

graph TD
    ABCG2["ABCG2"] -->|"associated"| Alzheimer["Alzheimer"]
    ABCG2["ABCG2"] -->|"therapeutic target"| Dementia["Dementia"]
    ABCG2["ABCG2"] -->|"associated"| Depression["Depression"]
    ABCG2["ABCG2"] -->|"associated"| Anxiety["Anxiety"]
    ABCG2["ABCG2"] -->|"regulates"| Inflammation["Inflammation"]
    ABCG2["ABCG2"] -->|"therapeutic target"| Ms["Ms"]
    MAOB["MAOB"] -->|"associated"| ABCG2["ABCG2"]
    GABRA1["GABRA1"] -->|"associated"| ABCG2["ABCG2"]
    CHAT["CHAT"] -->|"associated"| ABCG2["ABCG2"]
    CYP2D6["CYP2D6"] -->|"associated"| ABCG2["ABCG2"]
    style ABCG2 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0

Outgoing (155)

TargetRelationTypeStr
Cancertherapeutic_targetdisease0.75
Tumortherapeutic_targetdisease0.75
Alzheimerassociated_withdisease0.65
Dementiatherapeutic_targetdisease0.65
Depressionassociated_withdisease0.65

Incoming (75)

SourceRelationTypeStr
AMPKactivatesgene0.70
MAOBassociated_withgene0.60
GABRA1associated_withgene0.60
CHATassociated_withgene0.60
CYP2D6associated_withgene0.60

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found